ebook img

INVESTOR & ANALYST MEETING December 15, 2016 PDF

106 Pages·2016·6.11 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview INVESTOR & ANALYST MEETING December 15, 2016

INVESTOR & ANALYST MEETING December 15, 2016 Forward Looking Statements Statementsinthispresentationthatarenotstrictlyhistorical,includinganystatementsregardingeventsordevelopmentsthatwebelieveoranticipatewillormay occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, deterioration of or instability in the economy, the marketsweserveandthefinancialmarkets,theimpactofourrestructuringactivitiesonourabilitytogrow,contractionsorgrowthratesandcyclicalityofmarkets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conductbyouremployees,agentsorbusinesspartners,ourabilitytosuccessfullyidentify,consummateandintegrateappropriateacquisitionsandsuccessfully completedivestituresand otherdispositions,ourabilityto integratetherecent acquisitionsofPall Corporation and Cepheid and achievetheanticipated benefits of those transactions, contingent liabilities relating to acquisitions and divestitures (including tax-related and other contingent liabilities relating to the distributions of each of Fortive Corporation and our communications business), our compliance with applicable laws and regulations (including regulations relating to medical devices and the healthcare industry) and changes in applicable laws and regulations, our ability to effectively address cost reductions and other changes in the healthcare industry, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, the impact of our debt obligations on our operations and liquidity, our relationships with and the performance of our channel partners, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, labor matters, international economic, political, legal, compliance and business factors (including the impact of the UK referendum to leave the EU), disruptions relating to man-made and natural disasters, securitybreachesorotherdisruptionsofourinformationtechnologysystemsandpensionplancosts.Additionalinformationregardingthefactorsthatmaycause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2015 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third quarter of 2016. These forward-looking statements speak only as of the date of this presentation and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise. With respect to any non-GAAP financial measures included in the following presentation, the accompanying information required by SEC Regulation G can be foundinthe“Investors”sectionofDanaher’swebsite,www.danaher.com,undertheheading“Events&Presentations,”andeventname“Danaher2016Investor& AnalystMeeting.”Allreferencesinthispresentationtoearnings,revenuesandothercompany-specificfinancialmetricsrelateonlytothecontinuingoperationsof Danaher’sbusiness,unlessotherwisenoted.Allreferencesinthispresentationto“growth”orotherperiod-to-periodchangesrefertoyear-over-yearcomparisons unlessotherwiseindicated.Wemayalsodescribecertainproductsanddeviceswhichhaveapplicationssubmittedandpendingforcertainregulatoryapprovals. Agenda 9:30 am Welcome Matt Gugino 9:35 am Opening Remarks Tom Joyce 10:05 am Life Sciences Dan Daniel Pall Rainer Blair Water Quality Lance Reisman Q&A Daniel, Blair, Reisman 11:00 am Break All 11:20 am Diagnostics Arnd Kaldowski Product Identification Joakim Weidemanis Dental Amir Aghdaei Q&A Kaldowski, Weidemanis, Aghdaei 12:15 pm Closing Remarks & Guidance Tom Joyce 12:25 pm Q&A Tom Joyce 12:40 pm Program End / Lunch OPENING REMARKS Tom Joyce, President & CEO Danaher Today Life Environmental & Diagnostics Dental Sciences Applied Solutions ~$5.3B revenue ~$5.0B revenue ~$2.8B revenue ~$3.7B revenue Water Quality Product ID All financial metrics shown reflect 2016 estimated (“2016E”) revenues from continuing operations. Building a multi-industry, science & technology company 2016 Highlights Team executing well in current macro environment Consistent core revenue growth across all 4 segments Estimated FCF of ~$2.5B expected to exceed Net Income for 25th consecutive year Expanding margins while reinvesting Core OMX up 90bps YTD Ex-Pall GM up 130bps y/y, G&A* down, R&D/S&M* up 90bps Announced and closed ~$5B in acquisitions, including Cepheid and Phenomenex ~10 deals across all 5 platforms Completed separation of Fortive in July * As a % of total revenues. All figures on this slide are for the nine months ended September 30, 2016 unless otherwise indicated. ~20% adjusted EPS growth y/y expected in 2016 What You’ll Hear Today Danaher Business System is our culture and our competitive advantage Outstanding portfolio with significant growth and margin opportunities Superior FCF generation and disciplined M&A help drive compounding long-term returns DBS is Our Culture DBS Principles and 8 Core Value Drivers Core Growth OMX Shareholder Cash Flow / WC Turns Leadership ROIC Quality (External PPM) Customer On-Time Delivery Growth Lean Internal Fill Rate Associate Retention “OMX” is Operating Margin Expansion; “WC” is Working Capital Expand capabilities, drive consistent execution, sustain results

Description:
of the UK referendum to leave the EU), disruptions relating to man-made and natural disasters, . Strategic priorities have helped drive portfolio evolution . Pre-Clinical /. Clinical. Process. Development. Market. Growth. Workflow.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.